Acumen Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $61,138,000.
Profit Margin
| 2019 | 1.69M | -7.86M | -463.29% |
|---|---|---|---|
| 2020 | 1.43M | -7.32M | -510.03% |
| 2021 | 0 | -181.67M | |
| 2022 | 0 | -40.47M | |
| 2023 | 0 | -52.37M |
ABOS Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 1.43M | 1.69M |
Cost of revenue | 42.31M | 169K | 4K | 7.99K | 8.57K |
Gross profit | -42.31M | -169K | -4K | 1.42M | 1.68M |
Operating exp. | |||||
Research and development | 42.31M | 32.36M | 12.30M | 7.99M | 8.57M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 61.13M | 45.23M | 19.58M | 9.34M | 9.50M |
Operating income | -61.13M | -45.23M | 61.57M | -7.91M | -7.80M |
Other income (expenses), net | 8.76M | 2.38M | -162.17M | 587K | -102K |
Income before tax | -52.37M | -42.85M | -100.60M | -7.32M | -7.90M |
Income tax expense | 0 | -2.38M | 81.07M | -1K | -45K |
Net income | -52.37M | -40.47M | -181.67M | -7.32M | -7.86M |
Earnings per share | |||||
Basic EPS | -1.08 | -1 | -4.49 | -0.18 | -0.2 |
Diluted EPS | -1.08 | -1 | -4.49 | -0.18 | -0.2 |
| Data source | Data source | Data source |